These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9214449)

  • 1. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
    Bolognesi M; Sacerdoti D; Merkel C; Gatta A
    J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
    Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
    Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders.
    Berzigotti A; Rinaldi MF; Magalotti D; Morelli MC; Zappoli P; Andreone P; Rossi C; Zoli M
    J Hepatol; 2006 Feb; 44(2):310-6. PubMed ID: 16343679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
    García-Pagán JC; Villanueva C; Albillos A; Bañares R; Morillas R; Abraldes JG; Bosch J;
    Gut; 2009 Aug; 58(8):1144-50. PubMed ID: 19218249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
    Merkel C; Gatta A; Donada C; Enzo E; Marin R; Amodio P; Torboli P; Angeli P; Cavallarin G; Sebastianelli G
    Hepatology; 1995 Sep; 22(3):808-13. PubMed ID: 7657286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Villanueva C; Graupera I; Aracil C; Alvarado E; Miñana J; Puente Á; Hernandez-Gea V; Ardevol A; Pavel O; Colomo A; Concepción M; Poca M; Torras X; Reñe JM; Guarner C
    Hepatology; 2017 May; 65(5):1693-1707. PubMed ID: 28100019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
    Merkel C; Sacerdoti D; Bolognesi M; Buonamico P; Sticca A; Amodio P; Angeli P; Micotti L; Gatta A
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1221-5. PubMed ID: 10563530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
    Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
    N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.